(Q24610169)

1

0 references

J J Swen

2

0 references

C F Thorn

3

0 references

K Sangkuhl

4

0 references

E D Kharasch

5

0 references

V L Ellingrod

6

0 references

T C Skaar

7

0 references

D J Müller

8

0 references

A Gaedigk

9

0 references

J C Stingl

Clinical Pharmacology & Therapeutics

10

0 references

language of work or name

English

0 references

publication date

May 2013

0 references

published in

0 references

volume

93

0 references

page(s)

402-8

0 references

issue

5

0 references

cites work

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Pharmacogenetics: from bench to byte--an update of guidelines

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Management of cancer pain: basic principles and neuropathic cancer pain

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Pharmacologic management of neuropathic pain: evidence-based recommendations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Achieving remission and managing relapse in depression.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

The treatment of neuropathic pain: antidepressants and opioids

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Metabolism of tricyclic antidepressants

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

The emerging role of cytochrome P450 3A in psychopharmacology

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Cytochrome P450 monooxygenases and interactions of psychotropic drugs: a five-year update

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Clinical implications of the pharmacokinetics of tricyclic antidepressants

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype

30 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

Plasma 10-hydroxynortriptyline and renal function in elderly depressives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.2

Association between CYP2C19 polymorphism and depressive symptoms

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3689226

The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma

28 November 2018

1 reference

12 December 2020

Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients

1 reference

12 December 2020

Association of CYP2D6 Genotypes and Personality Traits in Healthy Individuals

1 reference

12 December 2020

Single-dose kinetics predict steady-state concentrations on imipramine and desipramine

1 reference

12 December 2020

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

1 reference

12 December 2020

10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes

1 reference

12 December 2020

Steady-state kinetics of fluoxetine and amitriptyline in patients treated with a combination of these drugs as compared with those treated with amitriptyline alone

1 reference

12 December 2020

Pronounced differences in the dispositon of clomipramine between Japanese and Swedish patients

1 reference

12 December 2020

The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/CLPT.2013.2

1 reference

Dimensions Publication ID

1352854

1024615269

0 references

1352854

1 reference

1 reference

1 reference